Afficher la couverture 'IOIBD Recommendations for Clinical Trials in Ulcerative Proctitis: The PROCTRIAL Consensus | Caron, Bénédicte' en grand format
/5

0 avis

IOIBD Recommendations for Clinical Trials in Ulcerative Proctitis: The PROCTRIAL Consensus

Archive ouverte

Caron, Bénédicte | Abreu, Maria | Siegel, Corey | Panaccione, Remo | Sands, Bruce | Dignass, Axel | Turner, Dan | Dotan, Iris | Hart, Ailsa | Ahuja, Vineet | Allez, Matthieu | Ananthakrishnan, Ashwin | Ghosh, Subrata | Griffiths, Anne | Halfvarson, Jonas | Kaser, Arthur | Kotze, Paulo | Koutroubakis, Ioannis | Lakatos, Peter | Levine, Arie | Lewis, James | Magro, Fernando | Mantzaris, Gerassimos | O'Morain, Colm | Ran, Zhihua | Reinisch, Walter | Rogler, Gerhard | Sachar, David | Siegmund, Britta | Silverberg, Mark | Sood, Ajit | Spinelli, Antonino | Steinwurz, Flavio | Tysk, Curt | Yamamoto-Furusho, Jesus | Schreiber, Stefan | Rubin, David | Sandborn, William | Danese, Silvio | Peyrin‐biroulet, Laurent

Edité par CCSD ; WB Saunders -

International audience. Clinical trials evaluating biologics and small molecules in patients with ulcerative colitis are predominantly excluding ulcerative proctitis. The objective of the Definition and endpoints for ulcerative PROCtitis in clinical TRIALs initiative was to develop consensus statements for definitions, inclusion criteria, and endpoints for the evaluation of ulcerative proctitis in adults.

Consulter en ligne

Suggestions

Du même auteur

Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases

Archive ouverte | Guillo, Lucas | CCSD

International audience. Extraintestinal manifestations occur frequently in patients with inflammatory bowel disease (IBD) and remain a diagnostic and therapeutic challenge. The aim of the Endpoints for Extraintestin...

CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease

Archive ouverte | Ma, Christopher | CCSD

International audience. End points to determine the efficacy and safety of medical therapies for Crohn's disease (CD) and ulcerative colitis (UC) are evolving. Given the heterogeneity in current outcome measures, ha...

I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease

Archive ouverte | Peyrin-Biroulet, Laurent | CCSD

International audience. There is a need to evaluate the benefit-risk ratio of current therapies in inflammatory bowel disease (IBD) patients to provide the best quality of care. The primary objective of I-CARE (IBD ...

Chargement des enrichissements...